Objective The PHASE project aims at providing a central access point to powerful computing platforms running applications used in the pharmaceutical drug discovery process (e.g. MaxHom, Genequiz, Dragon and Msap).By linking WAN connected HPCN systems running these applications, a service is provided to industrial users who need high performance computing power for their specific tasks in drug design projects, but find the cost to be prohibitive, or have not decided yet to invest in the acquisition and management of the software and platforms.Building on previous projects, and on a national metacomputing initiative, PHASE combines important paralel bio-informatics applications for collaborative use in a distributed server environment.Based on the results and experiences gained in these projects, PHASE has the potential to demonstrate the feasibility and cost-effectiveness of HPCN in industrial key-applications in the field of pharmaceutical drug design, and in biotechnology research.Moreover the project intends to demonstrate that this type of service, accessible also through Internet, may be extended to other application codes, and other industrial sectors. Fields of science medical and health sciencesbasic medicinepharmacology and pharmacydrug discoverynatural sciencescomputer and information sciencesinternetmedical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsmedical and health sciencesbasic medicinemedicinal chemistryengineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringcomputer hardwaresupercomputers Programme(s) FP4-ESPRIT 4 - Specific research and technological development programme in the field of information technologies, 1994-1998 Topic(s) 6.10 - HPCN Software and Systems Technology Call for proposal Data not available Funding Scheme CSC - Cost-sharing contracts Coordinator Universität- Gh - Paderborn EU contribution No data Address Fürstenallee 11 33102 Paderborn Germany See on map Total cost No data Participants (4) Sort alphabetically Sort by EU Contribution Expand all Collapse all EUROPEAN MOLECULAR BIOLOGY LABORATORY United Kingdom EU contribution No data Address Wellcome Trust Genome Campus, Hinxton Hall CB10 1SD SAFFRON WALDEN See on map Total cost No data MERCK KGAA Germany EU contribution No data Address Frankfurter Strasse 250 DARMSTADT See on map Links Website Opens in new window Total cost No data National Institute for Medical Research United Kingdom EU contribution No data Address Park Crescent 20 WIN 4AL London See on map Total cost No data Novo Nordisk A/S Denmark EU contribution No data Address Novo Allee 2880 Bagsvaerd See on map Total cost No data
